Literature DB >> 33551450

The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin.

Stephen Fitter1,2, Andrew C W Zannettino3,4,5, Pawanrat Tangseefa3,4, Sally K Martin3,4, Peck Yin Chin6, James Breen7,8,9, Chui Yan Mah3,4,10, Paul A Baldock11, Gary A Wittert3,10,12, Amanda J Page3,12, Christopher G Proud12,13.   

Abstract

Overnutrition causes hyperactivation of mTORC1-dependent negative feedback loops leading to the downregulation of insulin signaling and development of insulin resistance. In osteoblasts (OBs), insulin signaling plays a crucial role in the control of systemic glucose homeostasis. We utilized mice with conditional deletion of Rptor to investigate how the loss of mTORC1 function in OB affects glucose metabolism under normal and overnutrition dietary states. Compared to the controls, chow-fed Rptorob-/- mice had substantially less fat mass and exhibited adipocyte hyperplasia. Remarkably, upon feeding with high-fat diet, mice with pre- and post-natal deletion of Rptor in OBs were protected from diet-induced obesity and exhibited improved glucose metabolism with lower fasting glucose and insulin levels, increased glucose tolerance and insulin sensitivity. This leanness and resistance to weight gain was not attributable to changes in food intake, physical activity or lipid absorption but instead was due to increased energy expenditure and greater whole-body substrate flexibility. RNA-seq revealed an increase in glycolysis and skeletal insulin signaling pathways, which correlated with the potentiation of insulin signaling and increased insulin-dependent glucose uptake in Rptor-knockout osteoblasts. Collectively, these findings point to a critical role for the mTORC1 complex in the skeletal regulation of whole-body glucose metabolism and the skeletal development of insulin resistance.

Entities:  

Year:  2021        PMID: 33551450     DOI: 10.1038/s41413-020-00123-z

Source DB:  PubMed          Journal:  Bone Res        ISSN: 2095-4700            Impact factor:   13.567


  75 in total

Review 1.  Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1.

Authors:  Sung Hee Um; David D'Alessio; George Thomas
Journal:  Cell Metab       Date:  2006-06       Impact factor: 27.287

2.  Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion.

Authors:  Akiko Mizokami; Yu Yasutake; Sen Higashi; Tomoyo Kawakubo-Yasukochi; Sakura Chishaki; Ichiro Takahashi; Hiroshi Takeuchi; Masato Hirata
Journal:  Bone       Date:  2014-09-16       Impact factor: 4.398

3.  Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.

Authors:  Mathieu Ferron; Jianwen Wei; Tatsuya Yoshizawa; Andrea Del Fattore; Ronald A DePinho; Anna Teti; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

4.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Authors:  Mathieu Ferron; Marc D McKee; Robert L Levine; Patricia Ducy; Gérard Karsenty
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

5.  Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

Authors:  Mathieu Ferron; Eiichi Hinoi; Gerard Karsenty; Patricia Ducy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

6.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

7.  The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts.

Authors:  Tatsuya Yoshizawa; Eiichi Hinoi; Dae Young Jung; Daisuke Kajimura; Mathieu Ferron; Jin Seo; Jonathan M Graff; Jason K Kim; Gerard Karsenty
Journal:  J Clin Invest       Date:  2009-08-10       Impact factor: 14.808

8.  FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice.

Authors:  Marie-Therese Rached; Aruna Kode; Barbara C Silva; Dae Young Jung; Susan Gray; Helena Ong; Ji-Hye Paik; Ronald A DePinho; Jason K Kim; Gerard Karsenty; Stavroula Kousteni
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

9.  Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition.

Authors:  Keertik Fulzele; Ryan C Riddle; Douglas J DiGirolamo; Xuemei Cao; Chao Wan; Dongquan Chen; Marie-Claude Faugere; Susan Aja; Mehboob A Hussain; Jens C Brüning; Thomas L Clemens
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

10.  Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a.

Authors:  Jianwen Wei; Timothy Hanna; Nina Suda; Gerard Karsenty; Patricia Ducy
Journal:  Diabetes       Date:  2013-09-05       Impact factor: 9.461

View more
  3 in total

1.  Deletion of Rptor in Preosteoblasts Reveals a Role for the Mammalian Target of Rapamycin Complex 1 (mTORC1) Complex in Dietary-Induced Changes to Bone Mass and Glucose Homeostasis in Female Mice.

Authors:  Pawanrat Tangseefa; Sally K Martin; Agnieszka Arthur; Vasilios Panagopoulos; Amanda J Page; Gary A Wittert; Christopher G Proud; Stephen Fitter; Andrew C W Zannettino
Journal:  JBMR Plus       Date:  2021-03-24

2.  Jian Pi Tiao Gan Yin alleviates obesity phenotypes through mTORC1/SREBP1 signaling in vitro and in vivo.

Authors:  Xiaoming Song; Lulu Han; Xiaowan Lin; Minghui Tian; Fenglei Sun; Bo Feng
Journal:  Ann Transl Med       Date:  2022-03

Review 3.  Role of Essential Amino Acids in Age-Induced Bone Loss.

Authors:  Ziquan Lv; Wenbiao Shi; Qian Zhang
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.